ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,655Medicare Part D Prescriptions Filled, Including Refills

Rank: 770 out of 2343

$196K Total Retail Price of All Prescriptions

Rank: 1578 out of 2343

466 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 466 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

11% of this provider’s 466 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,472 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$26 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 301 283 1 1
OMEPRAZOLE 273 247 2 4
LEVOTHYROXINE SODIUM 228 204 3 2
HYDROCODONE-ACETAMINOPHEN 217 128 S3 4 13
FUROSEMIDE 198 182 5 6
LISINOPRIL 195 165 6 3
ASPIRIN EC 181 178 7 179
METOPROLOL TARTRATE 170 154 8 7
CITALOPRAM HBR 156 143 9 17
METFORMIN HCL 142 87 10 9
AMLODIPINE BESYLATE 132 115 11 5
ATENOLOL 125 112 12 12
TAMSULOSIN HCL 119 93 13 29
CALCIUM 500 + VIT D 107 99 10 14 314
VITAMIN D 102 102 15 201
GABAPENTIN 94 75 16 16
TRAMADOL HCL 91 70 17 25
RISPERIDONE 84 82 18 61
SENNA PLUS 84 84 18 278
HYDROCHLOROTHIAZIDE 83 64 20 11
WARFARIN SODIUM 83 76 20 8
ARTHRITIS PAIN RELIEF 78 62 22 337
FAMOTIDINE 76 66 23 60
POTASSIUM CHLORIDE 74 57 24 18
DONEPEZIL HCL 73 72 25 21
VITAMIN B-12 63 57 26 290
TRAZODONE HCL 61 39 27 53
ATORVASTATIN CALCIUM 59 38 28 10
FLUTICASONE PROPIONATE 59 40 28 46
MIRTAZAPINE 58 56 30 41
PREDNISONE 57 52 31 37
SERTRALINE HCL 54 39 32 20
OXYCODONE-ACETAMINOPHEN 52 41 S2 33 49
CARVEDILOL 51 51 34 27
MECLIZINE HCL 50 50 35 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.